Tirzepatide
Tirzepatide is a synthetic peptide consisting of 39 amino acids that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual receptor activity has been extensively studied for its effects on appetite regulation, energy intake, glucose metabolism, and metabolic function.
Tirzepatide
Sale!
Tirzepatide is a synthetic peptide consisting of 39 amino acids that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual receptor activity has been extensively studied for its effects on appetite regulation, energy intake, glucose metabolism, and metabolic function.
$169.00
Buy more, save more!
-
Save 1%
Buy 3, get $2.50 off each
$169.00Per item: $166.50Total price: $499.50 -
Save 2%
Buy 5, get $3.75 off each
$169.00Per item: $165.25Total price: $826.25 -
Save 4%
Buy 10, get $7.50 off each
$169.00Per item: $161.50Total price: $1,615.00
$199.00$169.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Tirzepatide is predominantly based on the native GIP sequence with modifications that confer GLP-1 receptor agonist activity, including a C20 fatty diacid side chain that promotes reversible albumin binding.
Preclinical studies in animal models of obesity and type 2 diabetes have shown that simultaneous activation of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) pathways may produce greater reductions in body weight, food intake, and adiposity than activation of either pathway alone.
Tirzepatide has also been extensively evaluated in large Phase 3 clinical programs, including the SURPASS and SURMOUNT trials, where it demonstrated significant improvements in glycated hemoglobin (HbA1c) and body weight.
In addition to its metabolic effects, Tirzepatide has been investigated for its effects on cardiovascular risk factors, with clinical studies evaluating its cardiovascular safety and outcomes.
There are no reviews yet.